HK Stock MarketDetailed Quotes

01548 GENSCRIPT BIO

Watchlist

12.100
-0.580-4.57%

Noon Break Mar 31 11:59 CST

26.14BMarket Cap1.14P/E (TTM)

GENSCRIPT BIO Key Stats

Cash Flow

All

YOY

Hide blank lines

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(Q6)Jun 30, 2020

Turnover

6.07%594.49M

43.46%561.37M

-10.42%560.48M

26.40%391.31M

27.67%625.7M

34.86%309.59M

25.39%490.1M

37.97%229.57M

42.98%390.85M

36.53%166.39M

Operating income

6.07%594.49M

43.46%561.37M

-10.42%560.48M

26.40%391.31M

27.67%625.7M

34.86%309.59M

25.39%490.1M

37.97%229.57M

42.98%390.85M

36.53%166.39M

Cost of sales

-11.22%-322.36M

-17.63%-254.39M

9.88%-289.85M

-53.28%-216.26M

-54.94%-321.62M

-55.13%-141.09M

-53.82%-207.58M

-56.21%-90.95M

-45.01%-134.95M

-35.46%-58.22M

Operating expenses

-11.22%-322.36M

-17.63%-254.39M

9.88%-289.85M

-53.28%-216.26M

-54.94%-321.62M

-55.13%-141.09M

-53.82%-207.58M

-56.21%-90.95M

-45.01%-134.95M

-35.46%-58.22M

Gross profit

0.55%272.13M

75.37%306.99M

-11.00%270.63M

3.89%175.05M

7.63%304.08M

21.55%168.5M

10.40%282.52M

28.15%138.62M

41.93%255.89M

37.10%108.17M

Selling expenses

-9.96%-88.12M

-19.57%-97.34M

52.40%-80.14M

6.37%-81.4M

-0.23%-168.35M

-49.21%-86.94M

-56.48%-167.97M

-41.92%-58.27M

-52.56%-107.34M

-32.62%-41.06M

Administrative expenses

-7.07%-114.38M

-12.82%-120.17M

41.46%-106.82M

-33.73%-106.52M

-35.65%-182.46M

-41.44%-79.65M

-48.89%-134.51M

-54.85%-56.31M

-63.50%-90.34M

-38.98%-36.37M

Research and development expenses

-2.07%-53.79M

-14.01%-236.38M

86.49%-52.7M

-16.74%-207.33M

-8.84%-390.1M

-1.41%-177.61M

-36.07%-358.4M

-51.69%-175.13M

-41.60%-263.4M

-83.73%-115.45M

Revaluation surplus

-195.65%-123.58M

-226.82%-113.51M

588.41%129.21M

24.21%-34.73M

113.46%18.77M

-2,764.00%-45.82M

-74.32%-139.43M

98.00%-1.6M

---79.98M

-Changes in the fair value of other assets

-195.65%-123.58M

-226.82%-113.51M

588.41%129.21M

24.21%-34.73M

113.46%18.77M

-2,764.00%-45.82M

-74.32%-139.43M

98.00%-1.6M

---79.98M

Impairment and provision

-216.78%-52.07M

-1,646.64%-41.34M

-30.15%-16.44M

-54.20%-2.37M

---12.63M

-24.70%-1.54M

----

---1.23M

----

-Other impairment is provision

-216.78%-52.07M

-1,646.64%-41.34M

-30.15%-16.44M

-54.20%-2.37M

---12.63M

-24.70%-1.54M

----

---1.23M

----

Operating interest expense

----

---3.3M

56.22%-2.38M

----

-595.52%-5.43M

-1,065.37%-4.51M

Special items of operating profit

11.94%36.12M

339.66%110.4M

163.12%32.27M

835.07%25.11M

189.29%12.26M

-170.55%-3.42M

-54.41%4.24M

-56.10%4.84M

-54.86%9.3M

99.46%11.03M

Operating profit

-170.28%-123.69M

17.58%-191.36M

142.06%176.01M

-1.05%-232.19M

18.90%-418.42M

-54.13%-229.78M

-83.40%-515.93M

5.74%-149.08M

-152.22%-281.31M

-340.32%-158.17M

Financing cost

-39.95%-8.03M

-14.15%-14.23M

56.75%-5.74M

---12.46M

---13.27M

----

---1.14M

----

Share of profits of associates

-2,723.12%-39.07M

----

---1.38M

----

-94.48%-599K

-125.90%-314K

Special items of earning before tax

----

-20,614.29%-1.44M

----

100.38%7K

177.46%433K

Earning before tax

-201.13%-170.8M

15.97%-205.59M

139.12%168.89M

-6.47%-244.65M

16.56%-431.69M

-52.96%-229.78M

-83.53%-517.36M

4.95%-150.22M

-147.95%-281.9M

-331.60%-158.05M

Tax

50.43%-2.98M

-809.69%-10.04M

-261.50%-6.01M

71.05%-1.1M

485.79%3.72M

35.65%-3.81M

-302.10%-964K

-140.66%-5.93M

112.47%477K

-174.97%-2.46M

After-tax profit from continuing operations

-206.69%-173.77M

12.26%-215.63M

138.06%162.88M

-5.21%-245.76M

17.43%-427.97M

-49.59%-233.59M

-84.18%-518.33M

2.72%-156.15M

-139.48%-281.42M

-381.50%-160.51M

After-tax profit from non-continuing business

684.76%3.03B

----

---518M

----

Earning after tax

904.03%2.86B

12.26%-215.63M

17.02%-355.12M

-5.21%-245.76M

17.43%-427.97M

-49.59%-233.59M

-84.18%-518.33M

2.72%-156.15M

-139.48%-281.42M

-381.50%-160.51M

Minority profit

58.95%-106.59M

73.38%-40.52M

-29.10%-259.64M

-55.15%-152.18M

-26.00%-201.12M

-50.83%-98.08M

-108.71%-159.62M

-37.14%-65.03M

-271.18%-76.48M

-691.73%-47.42M

Profit attributable to shareholders

3,202.19%2.96B

-87.13%-175.12M

57.91%-95.48M

30.94%-93.58M

36.76%-226.85M

-48.71%-135.51M

-75.03%-358.71M

19.43%-91.12M

-111.48%-204.95M

-313.56%-113.09M

Basic earnings per share

3,182.34%1.3963

-86.26%-0.0827

58.13%-0.0453

31.48%-0.0444

38.77%-0.1082

-40.56%-0.0648

-63.91%-0.1767

23.29%-0.0461

-106.12%-0.1078

-306.08%-0.0601

Diluted earnings per share

3,101.55%1.3597

-86.26%-0.0827

58.13%-0.0453

31.48%-0.0444

38.77%-0.1082

-40.56%-0.0648

-63.91%-0.1767

23.29%-0.0461

-106.12%-0.1078

-306.08%-0.0601

Currency Unit

USD

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(Q6)Jun 30, 2020
Turnover	6.07%594.49M	43.46%561.37M	-10.42%560.48M	26.40%391.31M	27.67%625.7M	34.86%309.59M	25.39%490.1M	37.97%229.57M	42.98%390.85M	36.53%166.39M
Operating income	6.07%594.49M	43.46%561.37M	-10.42%560.48M	26.40%391.31M	27.67%625.7M	34.86%309.59M	25.39%490.1M	37.97%229.57M	42.98%390.85M	36.53%166.39M
Cost of sales	-11.22%-322.36M	-17.63%-254.39M	9.88%-289.85M	-53.28%-216.26M	-54.94%-321.62M	-55.13%-141.09M	-53.82%-207.58M	-56.21%-90.95M	-45.01%-134.95M	-35.46%-58.22M
Operating expenses	-11.22%-322.36M	-17.63%-254.39M	9.88%-289.85M	-53.28%-216.26M	-54.94%-321.62M	-55.13%-141.09M	-53.82%-207.58M	-56.21%-90.95M	-45.01%-134.95M	-35.46%-58.22M
Gross profit	0.55%272.13M	75.37%306.99M	-11.00%270.63M	3.89%175.05M	7.63%304.08M	21.55%168.5M	10.40%282.52M	28.15%138.62M	41.93%255.89M	37.10%108.17M
Selling expenses	-9.96%-88.12M	-19.57%-97.34M	52.40%-80.14M	6.37%-81.4M	-0.23%-168.35M	-49.21%-86.94M	-56.48%-167.97M	-41.92%-58.27M	-52.56%-107.34M	-32.62%-41.06M
Administrative expenses	-7.07%-114.38M	-12.82%-120.17M	41.46%-106.82M	-33.73%-106.52M	-35.65%-182.46M	-41.44%-79.65M	-48.89%-134.51M	-54.85%-56.31M	-63.50%-90.34M	-38.98%-36.37M
Research and development expenses	-2.07%-53.79M	-14.01%-236.38M	86.49%-52.7M	-16.74%-207.33M	-8.84%-390.1M	-1.41%-177.61M	-36.07%-358.4M	-51.69%-175.13M	-41.60%-263.4M	-83.73%-115.45M
Revaluation surplus	-195.65%-123.58M	-226.82%-113.51M	588.41%129.21M	24.21%-34.73M	113.46%18.77M	-2,764.00%-45.82M	-74.32%-139.43M	98.00%-1.6M	---79.98M	---79.98M
-Changes in the fair value of other assets	-195.65%-123.58M	-226.82%-113.51M	588.41%129.21M	24.21%-34.73M	113.46%18.77M	-2,764.00%-45.82M	-74.32%-139.43M	98.00%-1.6M	---79.98M	---79.98M
Impairment and provision	-216.78%-52.07M	-1,646.64%-41.34M	-30.15%-16.44M	-54.20%-2.37M	---12.63M	-24.70%-1.54M	----	---1.23M	----	----
-Other impairment is provision	-216.78%-52.07M	-1,646.64%-41.34M	-30.15%-16.44M	-54.20%-2.37M	---12.63M	-24.70%-1.54M	----	---1.23M	----	----
Operating interest expense	----	----	----	----	----	---3.3M	56.22%-2.38M	----	-595.52%-5.43M	-1,065.37%-4.51M
Special items of operating profit	11.94%36.12M	339.66%110.4M	163.12%32.27M	835.07%25.11M	189.29%12.26M	-170.55%-3.42M	-54.41%4.24M	-56.10%4.84M	-54.86%9.3M	99.46%11.03M
Operating profit	-170.28%-123.69M	17.58%-191.36M	142.06%176.01M	-1.05%-232.19M	18.90%-418.42M	-54.13%-229.78M	-83.40%-515.93M	5.74%-149.08M	-152.22%-281.31M	-340.32%-158.17M
Financing cost	-39.95%-8.03M	-14.15%-14.23M	56.75%-5.74M	---12.46M	---13.27M	----	----	---1.14M	----	----
Share of profits of associates	-2,723.12%-39.07M	----	---1.38M	----	----	----	----	----	-94.48%-599K	-125.90%-314K
Special items of earning before tax	----	----	----	----	----	----	-20,614.29%-1.44M	----	100.38%7K	177.46%433K
Earning before tax	-201.13%-170.8M	15.97%-205.59M	139.12%168.89M	-6.47%-244.65M	16.56%-431.69M	-52.96%-229.78M	-83.53%-517.36M	4.95%-150.22M	-147.95%-281.9M	-331.60%-158.05M
Tax	50.43%-2.98M	-809.69%-10.04M	-261.50%-6.01M	71.05%-1.1M	485.79%3.72M	35.65%-3.81M	-302.10%-964K	-140.66%-5.93M	112.47%477K	-174.97%-2.46M
After-tax profit from continuing operations	-206.69%-173.77M	12.26%-215.63M	138.06%162.88M	-5.21%-245.76M	17.43%-427.97M	-49.59%-233.59M	-84.18%-518.33M	2.72%-156.15M	-139.48%-281.42M	-381.50%-160.51M
After-tax profit from non-continuing business	684.76%3.03B	----	---518M	----	----	----	----	----	----	----
Earning after tax	904.03%2.86B	12.26%-215.63M	17.02%-355.12M	-5.21%-245.76M	17.43%-427.97M	-49.59%-233.59M	-84.18%-518.33M	2.72%-156.15M	-139.48%-281.42M	-381.50%-160.51M
Minority profit	58.95%-106.59M	73.38%-40.52M	-29.10%-259.64M	-55.15%-152.18M	-26.00%-201.12M	-50.83%-98.08M	-108.71%-159.62M	-37.14%-65.03M	-271.18%-76.48M	-691.73%-47.42M
Profit attributable to shareholders	3,202.19%2.96B	-87.13%-175.12M	57.91%-95.48M	30.94%-93.58M	36.76%-226.85M	-48.71%-135.51M	-75.03%-358.71M	19.43%-91.12M	-111.48%-204.95M	-313.56%-113.09M
Basic earnings per share	3,182.34%1.3963	-86.26%-0.0827	58.13%-0.0453	31.48%-0.0444	38.77%-0.1082	-40.56%-0.0648	-63.91%-0.1767	23.29%-0.0461	-106.12%-0.1078	-306.08%-0.0601
Diluted earnings per share	3,101.55%1.3597	-86.26%-0.0827	58.13%-0.0453	31.48%-0.0444	38.77%-0.1082	-40.56%-0.0648	-63.91%-0.1767	23.29%-0.0461	-106.12%-0.1078	-306.08%-0.0601
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	--	--	--	--
Auditor	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights